Kymera Therapeutics (KYMR)
(Delayed Data from NSDQ)
$35.21 USD
-0.50 (-1.40%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $35.18 -0.03 (-0.09%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $-0.73 | 3.78% |
Earnings Summary
For their last quarter, Kymera Therapeutics (KYMR) reported earnings of -$0.25 per share, beating the Zacks Consensus Estimate of $-0.44 per share. This reflects a positive earnings surprise of 43.18%. Look out for KYMR's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of -$0.73 per share, reflecting a year-over-year decrease of 4.29%.
Earnings History
Price & Consensus
Zacks News for KYMR
Kymera Therapeutics, Inc. (KYMR) Expected to Beat Earnings Estimates: Should You Buy?
KYMR: What are Zacks experts saying now?
Zacks Private Portfolio Services